On the other hand, the lymphopenia observed in COVID-19 seems to be linked to the ability of the virus to infect T cells through the angiotensin-converting enzyme 2 (ACE2) receptors and CD147-spike protein [43]. Here, ACE2 is linked to lymphopenia.